Skip to main content

PROAIR RESPICLICK

SABA DPI

Albuterol sulfate · Teva Pharmaceuticals

Clinical Reference · Data reviewed June 2026

Active Medication & Mechanism

  • Albuterol sulfate SABA
    90 mcg albuterol per inhalation

    Short-acting beta2-adrenergic agonist. Produces rapid bronchodilation by relaxing airway smooth muscle via beta2-receptor activation.

FDA-Approved Dosing — Strength × Indication

90 mcg
Asthma FDA Approved
2 inhalations every 4–6 hours as needed → As needed; 1 inhalation may suffice Treatment or prevention of bronchospasm in adults with reversible obstructive airway disease.
Exercise-Induced Bronchospasm FDA Approved
2 inhalations 15–30 minutes before exercise → As needed Prevention of exercise-induced bronchospasm.

All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling

Rescue inhaler. Indicated for acute bronchospasm and as-needed symptom relief — onset within minutes. Increasing or frequent use signals worsening asthma control; the label advises reassessment of controller therapy.

Related Inhalers

For educational reference by healthcare professionals. Not medical advice and not for use in clinical decision-making. This workspace is not a substitute for clinical judgement, prescribing information, or product monographs — always verify doses and indications against the most current labelling. If you are a patient, do not use this site to make medication decisions — speak with your clinician.

Device images are original illustrations for identification aid only — actual devices and packaging may differ. This site is not affiliated with or endorsed by any pharmaceutical manufacturer. Clinical data last reviewed: June 2026.

Inhaler Database · © inhalerdatabase.com 2024–2026 — All rights reserved